Use of hormonal protection for chemotherapy-induced gonadotoxicity.
about
Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agentsA clinical research integration special program (CRISP) for young women with primary ovarian insufficiency'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.Major clinical research advances in gynecologic cancer in 2011.Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?Fertility considerations in young women with hematological malignancies.Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell TransplantationUnderstanding Fertility in Young Female Cancer Patients.Characterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary.Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.Breast cancer and fertility preservationPreserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.Cryopreservation of ovarian tissue in breast cancer patients: 10 years of experience.Cancer and fertility preservation: international recommendations from an expert meeting.Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians.Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.
P2860
Q28240178-D65EF6FA-24E8-475D-A3C2-45787C264B88Q28972322-094281E9-A2C5-4B81-A745-D25576905D32Q30360464-EE562497-CA63-4EA0-A4AB-7DD9B2E5C6B9Q35758722-F19D260C-7794-4867-AC49-985E5D06A59FQ35789448-A8317B8B-3078-440E-8B86-757431499BDFQ35864000-0A044B8A-5AB5-4463-9B97-2DA30CB7FF62Q36016181-A654D53B-0E36-45AF-BA69-1D6C07A07AFAQ36087035-5B48A897-8C77-46CD-9C78-E27F334AFD20Q36218039-B21F2CAE-2D1C-448D-8E78-074CA7CDE5B4Q37181877-DA9F5065-F630-44FA-9BFF-C4808FF4111FQ37213101-2D8A10DF-9299-49F8-B63F-293E9BF69E16Q37612074-C1EA9B32-EEB8-4F7A-AB52-00C7B078A4F5Q38397291-602C0D3D-3278-4255-86B2-9267C244EF8EQ39504996-4478B11F-9EEA-49C9-843A-DEC522AE4B06Q43106184-230E44DE-6EAE-4E2E-B728-4A93F72DF56AQ45902867-46FF8698-CFB1-4B5A-A2DE-3474F72D5ED3Q46144166-62E030C6-C532-4022-BEED-88C897404D90Q47547600-31081EEE-CD7F-4F7D-BF83-38A4F7764C65Q53272116-A68B6AB5-B50E-4806-B07B-830CE5BF6D3D
P2860
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@en
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@nl
type
label
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@en
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@nl
prefLabel
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@en
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@nl
P2093
P1476
Use of hormonal protection for chemotherapy-induced gonadotoxicity.
@en
P2093
Alison Ting
Brian Petroff
Byung Chul Jee
Chang Suk Suh
Jung Ryeol Lee
S Samuel Kim
Seok Hyun Kim
P304
P356
10.1097/GRF.0B013E3181F96CB1
P577
2010-12-01T00:00:00Z